Document/ExhibitDescriptionPagesSize
1: 10-Q Quarterly Report HTML 2.09M
2: EX-31.1 Certification -- §302 - SOA'02 HTML 26K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 26K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 23K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 23K
11: R1 Cover Page HTML 75K
12: R2 Condensed Consolidated Balance Sheets HTML 146K
13: R3 Condensed Consolidated Balance Sheets HTML 48K
(Parenthetical)
14: R4 Condensed Consolidated Statements of Income (Loss) HTML 116K
15: R5 Condensed Consolidated Statements of Comprehensive HTML 60K
Income (Loss)
16: R6 Condensed Consolidated Statements of Comprehensive HTML 28K
Income (Loss) (Parenthetical)
17: R7 Condensed Consolidated Statements of Changes in HTML 127K
Redeemable Preferred Stock and Shareholders'
Equity (Deficit)
18: R8 Condensed Consolidated Statements of Cash Flows HTML 139K
19: R9 Organization and Basis of Presentation HTML 59K
20: R10 Business Combinations HTML 91K
21: R11 Investments HTML 147K
22: R12 Fair Value Measurements HTML 118K
23: R13 Goodwill and Intangible Assets HTML 58K
24: R14 Medical Costs Payable HTML 47K
25: R15 Short-Term Borrowings HTML 25K
26: R16 Share-Based Compensation HTML 64K
27: R17 Redeemable Convertible Preferred Stock HTML 32K
28: R18 Net Loss Per Share HTML 42K
29: R19 Commitments and Contingencies HTML 30K
30: R20 Segment and Geographical Information HTML 114K
31: R21 Income Taxes HTML 29K
32: R22 Redeemable Noncontrolling Interest HTML 37K
33: R23 Direct Contracting HTML 40K
34: R24 Organization and Basis of Presentation (Policies) HTML 42K
35: R25 Organization and Basis of Presentation (Tables) HTML 44K
36: R26 Business Combinations (Tables) HTML 80K
37: R27 Investments (Tables) HTML 205K
38: R28 Fair Value Measurements (Tables) HTML 118K
39: R29 Goodwill and Intangible Assets (Tables) HTML 64K
40: R30 Medical Costs Payable (Tables) HTML 46K
41: R31 Share-Based Compensation (Tables) HTML 62K
42: R32 Net Loss Per Share (Tables) HTML 45K
43: R33 Segment and Geographical Information (Tables) HTML 110K
44: R34 Redeemable Noncontrolling Interest (Tables) HTML 36K
45: R35 Direct Contracting (Tables) HTML 33K
46: R36 ORGANIZATION AND BASIS OF PRESENTATION - Narrative HTML 43K
(Details)
47: R37 ORGANIZATION AND BASIS OF PRESENTATION - Schedule HTML 40K
of Operating Costs (Details)
48: R38 BUSINESS COMBINATIONS - Narrative (Details) HTML 94K
49: R39 BUSINESS COMBINATIONS - Schedule of Business HTML 141K
Acquisitions (Details)
50: R40 BUSINESS COMBINATIONS - Schedule of Pro Forma HTML 31K
Revenue and Net Loss (Details)
51: R41 INVESTMENTS - Schedule of Investment Securities HTML 87K
(Details)
52: R42 INVESTMENTS - Schedule of Investments in HTML 76K
Continuous Loss Position (Details)
53: R43 INVESTMENTS - Narrative (Details) HTML 54K
54: R44 INVESTMENTS - Schedule Of Available-for-sale HTML 52K
Securities Maturities (Details)
55: R45 FAIR VALUE MEASUREMENTS - Schedule of Fair Value HTML 101K
Measurement for Assets on a Recurring Basis
(Details)
56: R46 FAIR VALUE MEASUREMENTS - Schedule of Fair Value HTML 49K
Measurement of Financial Instruments Not Measured
on a Recurring Basis (Details)
57: R47 FAIR VALUE MEASUREMENTS - Schedule of Change in HTML 29K
Fair Value of Contingent Consideration (Details)
58: R48 GOODWILL AND INTANGIBLE ASSETS - Schedule of HTML 35K
Goodwill (Details)
59: R49 GOODWILL AND INTANGIBLE ASSETS - Schedule of HTML 40K
Definite-lived Intangible Assets (Details)
60: R50 GOODWILL AND INTANGIBLE ASSETS - Narrative HTML 28K
(Details)
61: R51 GOODWILL AND INTANGIBLE ASSETS - Schedule of HTML 36K
Intangible Asset Amortization Expense (Details)
62: R52 MEDICAL COSTS PAYABLE - Change in Medical Costs HTML 45K
Payable (Details)
63: R53 MEDICAL COSTS PAYABLE - Narrative (Details) HTML 24K
64: R54 MEDICAL COSTS PAYABLE - Components of Medical HTML 34K
Costs Payable (Details)
65: R55 Short-Term Borrowings (Details) HTML 47K
66: R56 SHARE-BASED COMPENSATION - Narrative (Details) HTML 76K
67: R57 SHARE-BASED COMPENSATION - Schedule of Stock HTML 34K
Option Valuation Assumptions (Details)
68: R58 SHARE-BASED COMPENSATION - Schedule of Stock HTML 57K
Option Activity (Details)
69: R59 SHARE-BASED COMPENSATION - Schedule of RSU and PSU HTML 53K
Activity (Details)
70: R60 Redeemable Convertible Preferred Stock (Details) HTML 57K
71: R61 NET LOSS PER SHARE - Schedule of Net Loss Per HTML 51K
share (Details)
72: R62 NET LOSS PER SHARE - Schedule of Antidilutive HTML 33K
Securities Excluded From Net Loss Per Share
(Details)
73: R63 Commitments and Contingencies (Details) HTML 24K
74: R64 SEGMENT AND GEOGRAPHICAL INFORMATION - Narrative HTML 32K
(Details)
75: R65 SEGMENT AND GEOGRAPHICAL INFORMATION - Schedule of HTML 67K
Segment Information (Details)
76: R66 Income Taxes (Details) HTML 26K
77: R67 REDEEMABLE NONCONTROLLING INTEREST - Schedule of HTML 34K
Redeemable Noncontrolling Interest (Details)
78: R68 DIRECT CONTRACTING - Narrative (Details) HTML 26K
79: R69 Direct Contracting (Details) HTML 36K
82: XML IDEA XML File -- Filing Summary XML 151K
80: XML XBRL Instance -- bhg-20220630_htm XML 2.83M
81: EXCEL IDEA Workbook of Financial Reports XLSX 161K
7: EX-101.CAL XBRL Calculations -- bhg-20220630_cal XML 271K
8: EX-101.DEF XBRL Definitions -- bhg-20220630_def XML 510K
9: EX-101.LAB XBRL Labels -- bhg-20220630_lab XML 1.71M
10: EX-101.PRE XBRL Presentations -- bhg-20220630_pre XML 999K
6: EX-101.SCH XBRL Schema -- bhg-20220630 XSD 168K
83: JSON XBRL Instance as JSON Data -- MetaLinks 426± 684K
84: ZIP XBRL Zipped Folder -- 0001671284-22-000039-xbrl Zip 443K
1.I have reviewed this Quarterly Report on Form 10-Q of Bright Health Group, Inc.;
2.Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.[Omitted];
c.evaluated
the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially
affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
